Recently, the clinical significance of tumor-specific markers, such as CEA, CA125, and HE4 (better than epithelial-specific markers: EPCAM and MUC1) for CTCs isolation before and after adjuvant chemotherapy was shown [25]. Here, MUC16 is linked to neoplasm.